hospitalised patient – Page 15 – Communicable Diseases Research

First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study

Research Article

Published on 2021-01-092022-10-28
Journal: BMC Infectious Diseases [Category] COVID-19, MERS,

The influence of pre-existing hypertension on coronavirus disease 2019 patients

Original Paper

Published on 2021-01-052022-11-01
Journal: Epidemiology and Infection [Category] COVID-19, MERS,

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry

Observational Study

Published on 2021-01-012022-10-05
Journal: RMD Open [Category] 임상,

[키워드] 1.26 95% CI Admission age Autoimmune Autoimmune diseases Care COVID-19 criteria Cyclophosphamide death diabete died disease eligible Emergency Care enrolled Epidemiology evaluate glucocorticoid Health Health care hospitalisation hospitalised hospitalised patient ICU ICU admission Immune-mediated Immunosuppression inflammatory process inhibitor intensive care Kidney disease majority mechanical ventilation median age Methylprednisolone Ministry of Health multicentre multivariate adjustment Necrosis outcome outcome and process assessment outcome assessment participant Patient patients Prevalence prospective cohort study Protective pulse remained required rheumatic disease risk factor systemic lupus erythematosus Therapeutics therapy variable women
[DOI] 10.1136/rmdopen-2020-001461 PMC 바로가기 [Article Type] Observational Study

Antibody response to SARS-CoV-2 infection in humans: A systematic review

인간의 SARS-CoV-2 감염에 대한 항체 반응: 체계적인 검토

Research Article

Published on 2020-12-312022-08-13
Journal: PLoS ONE [Category] Medicine and Health Sciences, MERS, SARS, 진단, 치료기술,

[키워드] Abstract acute phase acute respiratory syndrome antibody Antibody Response Antibody responses appraisal article assessment Asymptomatic asymptomatic infection carried characterising Characteristics clinically cohort study Comprehensive Consensus convalescent plasma Coronaviridae COVID-19 declining demographic characteristics described detectable determinant disease disease control disease onset disease severity eight evaluated Evidence evidenced finding FIVE heterogeneity hospitalised patient Hospitalised patients humoral immune response IgG IgM Immunity implication in vivo initial less limitation literature methodological limitations Mild MOST Neutralising Antibodies neutralising antibody neutralising antibody titre outcome pathogen peaked peaking post-symptom onset Progress protective immunity Public Quality reported researchers respiratory Result SARS-CoV-2 SARS-COV-2 infection screened Serological assay Seven Severe acute respiratory syndrome Specific statistical analysis Study participants symptom onset synthesised systematic review the antibody response the patient Therapeutics title titre titres Vaccines
[DOI] 10.1371/journal.pone.0244126 PMC 바로가기 [Article Type] Research Article

Cognitive impact of COVID-19: looking beyond the short term

Review

Published on 2020-12-302022-10-28
Journal: Alzheimer's Research & Therapy [Category] COVID-19, MERS, SARS,

[키워드] accelerate accumulating ACE inhibitor ACE-2 acute illness angiotensin receptor blocker Angiotensin receptor blockers Angiotensin-converting enzyme angiotensin-converting enzyme inhibitors angiotensin-converting enzyme-2 ApoE cardiorespiratory Central nervous system cerebral classical CNS Cognitive function Cognitive impairment COVID-19 COVID-19 patient current Dementia deplete develop disease Disseminated intravascular coagulation dysfunction Endothelial cell endothelial cells Evidence exacerbate exacerbating expression Follow-up hospitalised patient immune activation increased risk individuals infecting Inflammation inflammatory effect Lewy body Limited lowest medication Meta-analysis nasal mucosa Neurological complication neurons olfactory pathology Patient pericyte pericytes Phosphorylation predicted Protective RAS recent receptor reducing Respiratory disease Respiratory function risk SARS-CoV-2 SARS-CoV-2 entry SARS-CoV-2 virus Spread stroke suggested Survivors target therapy thrombosis vascular leakage vasculature virus White matter ischaemia
[DOI] 10.1186/s13195-020-00744-w PMC 바로가기 [Article Type] Review

Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial

입원한 중증 COVID-19 환자를 위한 치료제로서의 정맥내 메틸프레드니솔론 펄스: 무작위 대조 임상 시험의 결과

Randomized Controlled Trial

Published on 2020-12-242022-08-13
Journal: The European Respiratory Journal [Category] 임상,

[키워드] 1:1 95% CI administration Analysis attending physician Block randomisation Clinical improvement clinical trial conducted Controlled clinical trial Corticosteroid Corticosteroids COVID-19 COVID-19 patient COVID-19 patients death demonstrated eligible patient hazard ratio hospitalised hospitalised patient Immunosuppressive treatment Inflammation Inflammatory marker inflammatory markers initiation of treatment intention-to-treat Intravenous injection Iran ITT log-rank test Methylprednisolone methylprednisolone group mortality rate oxygen oxygen saturation Patient pulmonary involvement pulse randomisation randomised controlled Randomly receive reduce respiratory Respiratory system Result safety analysis severe adverse event severe adverse events severe COVID-19 severe COVID-19 patient significantly increased significantly lower single-blind standard care standard care group suggested survival survival time therapeutic therapeutic agent Treatment Two patient two patients was done were excluded
[DOI] 10.1183/13993003.02808-2020 PMC 바로가기 [Article Type] Randomized Controlled Trial

Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial

신속한 모집 및 보급이 Covid-19 사망률에 미치는 영향: RECOVERY 시험

Opinion Article

Published on 2020-12-232022-09-11
Journal: F1000Research [Category] MERS, 임상,

Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions

Observational Study

Published on 2020-12-232022-10-04
Journal: Internal and Emergency Medicine [Category] MERS, SARS, 임상,

[키워드] addition ADR ADRS Adverse drug reaction Adverse drug reactions age Caucasian patient Characteristics Clinical characteristics collected Comorbidities COVID-19 COVID-19 patient disorders drug–drug interaction Drug–drug interactions drugs effective evaluated Evidence Florence hospitalised hospitalised patient Hospitalised patients identify Interaction interactions internal medicine Italy less majority males medications outcome patients pharmacokinetic pharmacological pharmacovigilance preferred term Psychiatric QT interval QT prolongation reported resolved risk SARS-CoV-2 study period supplementary material treatments for COVID-19 unit university
[DOI] 10.1007/s11739-020-02586-8 PMC 바로가기 [Article Type] Observational Study

Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol

SARS-CoV-2(COVID-19) 양성 중환자에서 보조 요법으로 고용량 아연 정맥 주사에 대한 무작위 대조 시험: 시험 프로토콜

Article

Published on 2020-12-022022-09-11
Journal: BMJ Open [Category] SARS, 임상,

[키워드] Analysis caused Controlled trial coronavirus COVID-19 Critically ill demonstrated discharge distress double-blind duration of follow-up Effect Elemental end-organ Ethical approval Ethics ethics committee evaluate healthcare High-dose hospitalised patient Human hypoxic independent Infectious diseases Injury International intravenous lowest oxygen saturation mechanism non-ventilated patient non-ventilated patients oxygen oxygen saturation oxygen saturations oxygen supplementation Oxygenation pandemic PaO participant peer-reviewed Placebo positive primary outcome measure Primary outcome measures protective effect public health randomised controlled trial recruited recruitment reduction registration number Research Ethics respiratory respiratory distress Respiratory distress syndrome Respiratory illness respiratory infections Result resulting RNA polymerase robust SARS-CoV-2 SARS-COV-2 infection syndrome therapy Treatment trial protocol Vaccine ventilated patient ventilated patients Viral viral respiratory infection viral respiratory infections Virology was obtained Zinc
[DOI] 10.1136/bmjopen-2020-040580 PMC 바로가기 [Article Type] Article

Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties

COVID-19로 입원한 환자의 덱사메타손: 불확실성 해결

Article

Published on 2020-12-012022-09-11
Journal: The Lancet. Respiratory Medicine [Category] Fulltext, SARS, 임상,

[키워드] hospitalised patient
[DOI] 10.1016/S2213-2600(20)30503-8 PMC 바로가기 [Article Type] Article